Zhalyalov Ansar S, Panteleev Mikhail A, Gracheva Marina A, Ataullakhanov Fazoil I, Shibeko Alexey M
Center for Theoretical Problems of Physicochemical Pharmacology RAS, Moscow, Russia.
National Scientific and Practical Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
PLoS One. 2017 Jul 7;12(7):e0180668. doi: 10.1371/journal.pone.0180668. eCollection 2017.
Fibrinolysis is a cascade of proteolytic reactions occurring in blood and soft tissues, which functions to disintegrate fibrin clots when they are no more needed. In order to elucidate its regulation in space and time, fibrinolysis was investigated using an in vitro reaction-diffusion experimental model of blood clot formation and dissolution. Clotting was activated by a surface with immobilized tissue factor in a thin layer of recalcified blood plasma supplemented with tissue plasminogen activator (TPA), urokinase plasminogen activator or streptokinase. Formation and dissolution of fibrin clot was monitored by videomicroscopy. Computer systems biology model of clot formation and lysis was developed for data analysis and experimental planning. Fibrin clot front propagated in space from tissue factor, followed by a front of clot dissolution propagating from the same source. Velocity of lysis front propagation linearly depended on the velocity clotting front propagation (correlation r2 = 0.91). Computer model revealed that fibrin formation was indeed the rate-limiting step in the fibrinolysis front propagation. The phenomenon of two fronts which switched the state of blood plasma from liquid to solid and then back to liquid did not depend on the fibrinolysis activator. Interestingly, TPA at high concentrations began to increase lysis onset time and to decrease lysis propagation velocity, presumably due to plasminogen depletion. Spatially non-uniform lysis occurred simultaneously with clot formation and detached the clot from the procoagulant surface. These patterns of spatial fibrinolysis provide insights into its regulation and might explain clinical phenomena associated with thrombolytic therapy.
纤维蛋白溶解是发生在血液和软组织中的一系列蛋白水解反应,当不再需要纤维蛋白凝块时,其作用是分解这些凝块。为了阐明其在空间和时间上的调节机制,我们使用了一个体外血栓形成和溶解的反应扩散实验模型来研究纤维蛋白溶解。在补充了组织型纤溶酶原激活剂(TPA)、尿激酶型纤溶酶原激活剂或链激酶的再钙化血浆薄层中,通过固定化组织因子的表面激活凝血。通过视频显微镜监测纤维蛋白凝块的形成和溶解。开发了凝块形成和溶解的计算机系统生物学模型用于数据分析和实验规划。纤维蛋白凝块前沿从组织因子开始在空间中传播,随后是从同一来源传播的凝块溶解前沿。溶解前沿的传播速度与凝血前沿的传播速度呈线性相关(相关系数r2 = 0.91)。计算机模型显示,纤维蛋白的形成确实是纤维蛋白溶解前沿传播的限速步骤。两个前沿将血浆状态从液体转变为固体然后再变回液体的现象并不依赖于纤维蛋白溶解激活剂。有趣的是,高浓度的TPA开始增加溶解起始时间并降低溶解传播速度,这可能是由于纤溶酶原耗竭所致。空间上不均匀的溶解与凝块形成同时发生,并使凝块从促凝表面脱离。这些空间纤维蛋白溶解模式为其调节机制提供了见解,并可能解释与溶栓治疗相关的临床现象。